ETFs versus funds: how do they compare?
ETFs have been growing in popularity in recent years and now for the first time they have been included alongside…
3 years ago
Latest
John’s Mining Journal: Xtract Resources and Solgold
Veteran mining analyst John Cornford reviews some of the more interesting plays in the junior mining sector…
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
Mellon on the Markets: thoughts from Dubai
Inside the mind of the Master Investor: Influential British investor Jim Mellon reveals his latest thoughts on the markets.
3 years ago
Redcentric’s turnaround is bearing fruit
Clear of previous hassles, operating on over 87% ARR and with recovering profitability, Redcentric shares have excellent upside potential, writes…
3 years ago
Evil Knievil: A new Angle
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
3 years ago
Small-cap round-up featuring K3 Capital, Audioboom, Xpediator and more…
In this weekly summary, Mark Watson-Mitchell updates his readers on previous company profiles and other news of interest from the…
3 years ago
Hybridan Small Cap Feast
A round up of the day’s news brought to you by the team at small-cap broker and advisor Hybridan.
3 years ago
Journal of the Plague Years XVIII – AstraZeneca and the Unloved Vaccine
It was developed in record time and made available at cost price. It is easy to transport and store. It…
3 years ago
Evil Knievil: Muddling distances
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
3 years ago